Inge Thomas H, Courcoulas Anita P, Jenkins Todd M, Michalsky Marc P, Helmrath Michael A, Brandt Mary L, Harmon Carroll M, Zeller Meg H, Chen Mike K, Xanthakos Stavra A, Horlick Mary, Buncher C Ralph
From the Cincinnati Children's Hospital Medical Center (T.H.I., T.M.J., M.A.H., M.H.Z., S.A.X.) and the University of Cincinnati (C.R.B.), Cincinnati, and Nationwide Children's Hospital, Columbus (M.P.M.) - all in Ohio; the University of Pittsburgh Medical Center, Pittsburgh (A.P.C.); Texas Children's Hospital, Baylor College of Medicine, Houston (M.L.B.); Women and Children's Hospital, University of Buffalo, Buffalo, NY (C.M.H.); University of Alabama at Birmingham, Birmingham (M.K.C.); and the National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD (M.H.).
N Engl J Med. 2016 Jan 14;374(2):113-23. doi: 10.1056/NEJMoa1506699. Epub 2015 Nov 6.
Bariatric surgery is increasingly considered for the treatment of adolescents with severe obesity, but few prospective adolescent-specific studies examining the efficacy and safety of weight-loss surgery are available to support clinical decision making.
We prospectively enrolled 242 adolescents undergoing weight-loss surgery at five U.S. centers. Patients undergoing Roux-en-Y gastric bypass (161 participants) or sleeve gastrectomy (67) were included in the analysis. Changes in body weight, coexisting conditions, cardiometabolic risk factors, and weight-related quality of life and postoperative complications were evaluated through 3 years after the procedure.
The mean (±SD) baseline age of the participants was 17±1.6 years, and the mean body-mass index (the weight in kilograms divided by the square of the height in meters) was 53; 75% of the participants were female, and 72% were white. At 3 years after the procedure, the mean weight had decreased by 27% (95% confidence interval [CI], 25 to 29) in the total cohort, by 28% (95% CI, 25 to 30) among participants who underwent gastric bypass, and by 26% (95% CI, 22 to 30) among those who underwent sleeve gastrectomy. By 3 years after the procedure, remission of type 2 diabetes occurred in 95% (95% CI, 85 to 100) of participants who had had the condition at baseline, remission of abnormal kidney function occurred in 86% (95% CI, 72 to 100), remission of prediabetes in 76% (95% CI, 56 to 97), remission of elevated blood pressure in 74% (95% CI, 64 to 84), and remission of dyslipidemia in 66% (95% CI, 57 to 74). Weight-related quality of life also improved significantly. However, at 3 years after the bariatric procedure, hypoferritinemia was found in 57% (95% CI, 50 to 65) of the participants, and 13% (95% CI, 9 to 18) of the participants had undergone one or more additional intraabdominal procedures.
In this multicenter, prospective study of bariatric surgery in adolescents, we found significant improvements in weight, cardiometabolic health, and weight-related quality of life at 3 years after the procedure. Risks associated with surgery included specific micronutrient deficiencies and the need for additional abdominal procedures. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; Teen-LABS ClinicalTrials.gov number, NCT00474318.).
减肥手术越来越多地被用于治疗重度肥胖的青少年,但针对青少年减肥手术疗效和安全性的前瞻性特定研究较少,难以支持临床决策。
我们前瞻性地纳入了在美国五个中心接受减肥手术的242名青少年。接受 Roux-en-Y 胃旁路手术(161名参与者)或袖状胃切除术(67名)的患者被纳入分析。在手术后3年内评估体重变化、并存疾病、心脏代谢危险因素、与体重相关的生活质量和术后并发症。
参与者的平均(±标准差)基线年龄为17±1.6岁,平均体重指数(体重千克数除以身高米数的平方)为53;75%的参与者为女性,72%为白人。术后3年,整个队列的平均体重下降了27%(95%置信区间[CI],25至29),接受胃旁路手术的参与者中下降了28%(95%CI,25至30),接受袖状胃切除术的参与者中下降了26%(95%CI,22至30)。术后3年,基线时患有2型糖尿病的参与者中95%(95%CI,85至100)病情缓解,肾功能异常者中86%(95%CI,72至100)缓解,糖尿病前期者中76%(95%CI,56至97)缓解,高血压患者中74%(95%CI,64至84)缓解,血脂异常者中66%(95%CI,57至74)缓解。与体重相关的生活质量也有显著改善。然而,减肥手术后3年,57%(95%CI,50至65)的参与者出现低铁蛋白血症,13%(95%CI,9至18)的参与者接受了一次或多次额外的腹部手术。
在这项青少年减肥手术的多中心前瞻性研究中,我们发现术后3年体重、心脏代谢健康和与体重相关的生活质量有显著改善。手术相关风险包括特定的微量营养素缺乏和需要进行额外的腹部手术。(由美国国立糖尿病、消化和肾脏疾病研究所及其他机构资助;青少年减肥手术长期评估和随访研究[Teen-LABS],ClinicalTrials.gov编号,NCT00474318。)